• Our Story
    • Our Story
    • Meet the Shepherds
    • Rethinking Pharmacy
  • FAQs
  • From our Experts
  • Contact
  • Our Story
    • Our Story
    • Meet the Shepherds
    • Rethinking Pharmacy
  • FAQs
  • From our Experts
  • Contact
  • Our Story
    • Our Story
    • Meet the Shepherds
    • Rethinking Pharmacy
  • FAQs
  • From our Experts
  • Contact
Medication-Derived Nutrient Deficiencies: Why Patients Who Take Statins May Also Need CoQ10

Medication-Derived Nutrient Deficiencies: Why Patients Who Take Statins May Also Need CoQ10

by Dr. Phil Baker, PHARMD | Jan 13, 2025 | Haloscrips, Homepage, Population Health

Download the PDF Send download link to: Statins, including popular medications like Lipitor (atorvastatin) and Crestor (rosuvastatin), are among the most commonly prescribed drugs in the United States. Their ability to lower LDL cholesterol (the “bad” type) has...
Is 503B the New 340B?: The Role of Compounding Pharmacies in the Ever-Evolving Drug Supply chain

Is 503B the New 340B?: The Role of Compounding Pharmacies in the Ever-Evolving Drug Supply chain

by Dr. Phil Baker, PHARMD | Nov 22, 2024 | Haloscrips, Homepage, Population Health

Download the PDF Send download link to: To be honest, my heart sinks when I’m asked my opinion about the explosion of compounding pharmacies related to GLP-1 weight loss drugs (commonly known by brand names like Ozempic or Wegovy). It’s a complicated answer, and my...
The Rising Tide of GLP-1 Costs: Can Your Health Plan Stay Afloat?

The Rising Tide of GLP-1 Costs: Can Your Health Plan Stay Afloat?

by Michell Zulu, PharmD | Nov 18, 2024 | Haloscrips, Homepage, Population Health

Co-authors: Phil Baker, PharmD Download the PDF Send download link to: If one pharmacist calls another and asks if they have any of this year’s most popular drug, they don’t even have to say a name. It’s probably a GLP-1.  About 12% of U.S. adults have taken some type...
Value-Based Pharmacy: An Alternative to Volume-Based Models

Value-Based Pharmacy: An Alternative to Volume-Based Models

by Dr. Phil Baker, PHARMD | Oct 25, 2024 | Community Pharmacy, Haloscrips, Homepage, Population Health

A version of this article originally published in the Journal of the American Pharmacists Association Co-authors: Kenneth C. Hohmeier, PharmD, Associate Professor, Director of Community Affairs, University of Tennessee Health Science Center, College of Pharmacy,...
Evaluation of the RemediChain Pilot Program: A Retrospective Analysis

Evaluation of the RemediChain Pilot Program: A Retrospective Analysis

by Dr. Phil Baker, PHARMD | Jul 24, 2024 | Homepage, Prescription Reclamation

Co-authors: Michell Zulu, PharmD; Kelli Brignac Download the PDF Send download link to: Key Takeaways: The Blue Cross Blue Shield of North Carolina (BCNC) RemediChain Pilot Program demonstrated substantial growth in the number and value of reclaimed and redistributed...
Next Entries »

Recent Posts

  • Craig Thompson: Patient, Donor, Patient Again
  • A Caregiver’s Guide: Cleaning Out a Loved One’s Medications
  • Jeff Boyd: A Story of Hope
  • Financial Toxicity in Oncology: Practical Prescription Assistance Tools Beyond the Copay Card
  • Medication-Derived Nutrient Deficiencies: Why Patients on Blood Pressure Medications May Also Need Potassium and Zinc

744 Sanga Creek Rd., Suite A | Memphis, TN 38018
[email protected] | Call or text: (877) 521-6337 | Fax: (877) 830-2923
@2026 Good Shepherd Health | Privacy Policy | Designed by Disciple Design

OUR STORY
FAQS
FROM OUR EXPERTS
CONTACT
RETHINKING PHARMACY